Marta Sobas - Concepedia

Author

Marta Sobas

Wroclaw Medical University ORCID

Also Known As

M. A. Sobas, M. Sobas, Marta A. Sobas, Marta Anna Sobas, Marta Sobas, Sobas, M.A., Sobas, Marta, Sobas, Marta Anna

147

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Wroclaw Medical University Hospital Universitari i Politècnic La Fe Vall d'Hebron Hospital Universitari Hospital General Universitario de Albacete University Hospital of Basel

About

Marta Sobas is an author at Wroclaw Medical University specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	69
2	Immunology	3	3	40
3	Health Sciences	2	2	27
4	Natural Sciences	1	1	13
5	Marrow Transplantation	1	1	15

Marta Sobas

Publications

919

Citations

H-Index

Page 1

	Year	Citations
Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice Ralph Tiedt, Hui Hao-Shen, Marta Sobas, Blood	2007	430
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib Tiziano Barbui, Alessandro M. Vannucchi, Alberto Álvarez‐Larrán, Leukemia	2021	80
Concordance of assays designed for the quantification of JAK2V617F: a multicenter study Éric Lippert, François Girodon, E. Hammond, Haematologica	2008	76
Outcome of older (≥70 years) APL patients frontline treated with or without arsenic trioxide—an International Collaborative Study Sabine Käyser, Ramy Rahmé, David Martínez‐Cuadrón, Leukemia	2020	49
Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs Marta Sobas, Jean‐Jacques Kiladjian, Yan Beauverd, Blood Advances	2022	41
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 Tiziano Barbui, Valerio De Stefano, Alberto Álvarez‐Larrán, Blood Cancer Journal	2021	33
Characteristics, clinical outcomes, and risk factors of SARS-COV-2 infection in adult acute myeloid leukemia patients: experience of the PETHEMA group Tomás Palanques-Pastor, Juan Eduardo Megías‐Vericat, Pilar Martı́nez, Leukemia & lymphoma/Leukemia and lymphoma	2021	33
Ratio of Mutant JAK2-V617F to Wild Type Jak2 Determines the MPD Phenotypes in Transgenic Mice. Ralph Tiedt, Hui Hao-Shen, Marta Sobas, Blood	2007	27
Rearrangements involving 11q23.3/KMT2A in adult AML: mutational landscape and prognostic implications – a HARMONY study Alberto Hernández‐Sánchez, Teresa González, Marta Sobas, Leukemia	2024	22
Impact of Cytoreductive Drugs upon Outcomes in a Contemporary Cohort of Adolescent and Young Adults with Essential Thrombocythemia and Polycythemia Vera Yan Beauverd, Jean‐Christophe Ianotto, Kyaw Htin Thaw, Blood	2023	18

Page 1